BR112018004725A2 - método para a produção de oligossacarídeos de leite humano em hospedeiros microbianos com importação/exportação modificada e célula hospedeira microbiana - Google Patents

método para a produção de oligossacarídeos de leite humano em hospedeiros microbianos com importação/exportação modificada e célula hospedeira microbiana

Info

Publication number
BR112018004725A2
BR112018004725A2 BR112018004725A BR112018004725A BR112018004725A2 BR 112018004725 A2 BR112018004725 A2 BR 112018004725A2 BR 112018004725 A BR112018004725 A BR 112018004725A BR 112018004725 A BR112018004725 A BR 112018004725A BR 112018004725 A2 BR112018004725 A2 BR 112018004725A2
Authority
BR
Brazil
Prior art keywords
host cells
microbial
export
production
human milk
Prior art date
Application number
BR112018004725A
Other languages
English (en)
Inventor
Wartenberg Dirk
Jennewein Stefan
Original Assignee
Jennewein Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jennewein Biotechnologie Gmbh filed Critical Jennewein Biotechnologie Gmbh
Publication of BR112018004725A2 publication Critical patent/BR112018004725A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/01Hexosyltransferases (2.4.1)
    • C12Y204/01146Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (2.4.1.146)

Abstract

a presente invenção refere-se a métodos para a produção de oligossacarídeos em células hospedeiras bacterianas geneticamente modificadas, bem como às células hospedeiras geneticamente modificadas utilizadas nos métodos. a célula hospedeira geneticamente modificada compreende pelo menos uma glicosiltransferase recombinante e pelo menos uma sequência de ácido nucleico que codifica para uma proteína que permite a exportação do oligossacarídeo.
BR112018004725A 2015-09-12 2016-09-12 método para a produção de oligossacarídeos de leite humano em hospedeiros microbianos com importação/exportação modificada e célula hospedeira microbiana BR112018004725A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15184968.4A EP3141610A1 (en) 2015-09-12 2015-09-12 Production of human milk oligosaccharides in microbial hosts with engineered import / export
PCT/EP2016/071420 WO2017042382A1 (en) 2015-09-12 2016-09-12 Production of human milk oligosaccharides in microbial hosts with engineered import / export

Publications (1)

Publication Number Publication Date
BR112018004725A2 true BR112018004725A2 (pt) 2018-09-25

Family

ID=54148344

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018004725A BR112018004725A2 (pt) 2015-09-12 2016-09-12 método para a produção de oligossacarídeos de leite humano em hospedeiros microbianos com importação/exportação modificada e célula hospedeira microbiana

Country Status (11)

Country Link
US (3) US11046985B2 (pt)
EP (2) EP3141610A1 (pt)
JP (3) JP7069007B2 (pt)
KR (1) KR20180043297A (pt)
CN (1) CN108026556B (pt)
AU (1) AU2016319304B2 (pt)
BR (1) BR112018004725A2 (pt)
MX (2) MX2018003037A (pt)
PH (1) PH12018550020A1 (pt)
RU (1) RU2763170C2 (pt)
WO (1) WO2017042382A1 (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2701163T3 (es) 2014-01-20 2019-02-21 Jennewein Biotechnologie Gmbh Procedimiento para la purificación eficiente de oligosacáridos de la leche humana (HMO) neutros a partir de la fermentación microbiana
MX2020000969A (es) * 2017-07-26 2020-09-28 Jennewein Biotechnologie Gmbh Sialil-transferasas y su uso en la produccion de oligosacaridos sialilados.
WO2019209245A1 (en) * 2018-04-23 2019-10-31 Dupont Nutrition Biosciences Aps Increasing activity of 2' fucosyllactose transporters endogenous to microbial cells
SG11202010729XA (en) 2018-05-07 2020-11-27 Jennewein Biotechnologie Gmbh A SIMPLE METHOD FOR THE PURIFICATION OF LACTO-N-NEOTETRAOSE (LNnT) FROM CARBOHYDRATES OBTAINED BY MICROBIAL FERMENTATION
CN109554385B (zh) * 2018-07-24 2022-04-12 石家庄葛兰德生物科技有限公司 一种基因工程菌制备2-岩藻糖基乳糖的方法
CN109034378B (zh) * 2018-09-04 2023-03-31 腾讯科技(深圳)有限公司 神经网络的网络表示生成方法、装置、存储介质和设备
CA3115210A1 (en) * 2018-10-02 2020-04-09 Zimitech, Inc. Use of substrate importers for the export of oligosaccharides
CN109370948B (zh) * 2018-11-26 2020-08-04 江南大学 一株高产6-磷酸-β-半乳糖苷酶的乳酸乳球菌及其应用
CN109825465B (zh) * 2019-02-27 2021-11-12 光明乳业股份有限公司 基于平衡udp-糖供给合成乳酰-n-新四糖的重组枯草芽孢杆菌及其构建方法与应用
CN109735480B (zh) * 2019-02-27 2021-11-12 光明乳业股份有限公司 一种合成乳酰-n-新四糖的重组枯草芽孢杆菌及其构建方法与应用
CA3135164A1 (en) * 2019-04-02 2020-10-08 Spiber Inc. Method for producing recombinant protein
EP3751003A1 (en) 2019-06-12 2020-12-16 Jennewein Biotechnologie GmbH Production of fucosylated oligosaccharides in bacillus
JP2022541287A (ja) * 2019-07-19 2022-09-22 インバイオス エン.フェー. 宿主細胞におけるフコシルラクトースの産生
JP2022544267A (ja) * 2019-08-13 2022-10-17 アミリス,インコーポレイティド 酵母でのオリゴ糖産生の改善
EP3789495A1 (en) 2019-09-03 2021-03-10 Jennewein Biotechnologie GmbH Production of sialylated oligosaccharides in bacillus cells
WO2021019104A2 (en) 2019-09-18 2021-02-04 Basf Se A production host for producing human milk oligosaccharides
US20230068960A1 (en) 2019-09-24 2023-03-02 Prolacta Bioscience, Inc. Compositions and methods for treatment of inflammatory and immune diseases
KR20220114632A (ko) * 2019-12-18 2022-08-17 인바이오스 엔.브이. 숙주 세포에서 시알릴화 올리고당의 생산
EP3848471A1 (en) * 2020-01-10 2021-07-14 Chr. Hansen HMO GmbH Sequential fermentative production of oligosaccharides
AU2021209395A1 (en) * 2020-01-23 2022-07-14 Glycom A/S New major facilitator superfamily (MFS) protein (Fred) in HMO production
AU2021210607A1 (en) * 2020-01-23 2022-07-14 Glycom A/S HMO production
JP2023511525A (ja) * 2020-01-23 2023-03-20 グリコム・アクティーゼルスカブ HMO生産における新しい主要促進剤スーパーファミリー(MFS)タンパク質(Fred)
AU2021209394A1 (en) * 2020-01-23 2022-07-14 Glycom A/S HMO production
CN114981291A (zh) * 2020-01-23 2022-08-30 格礼卡姆股份公司 Hmo产生
WO2021202883A1 (en) * 2020-04-01 2021-10-07 Zimitech, Inc. Methods for production of oligosaccharides
EP3929300A1 (en) 2020-06-26 2021-12-29 Chr. Hansen HMO GmbH Improved export of oligosaccharides from bacterial cells
US20240139222A1 (en) 2020-08-14 2024-05-02 Prolacta Bioscience, Inc. Human milk oligosaccharide compositions for use with bacteriotherapies
CN111979168B (zh) * 2020-08-17 2022-07-22 江南大学 一种提高乳酰-n-三糖ii产量的基因工程菌及生产方法
US20240060056A1 (en) * 2020-12-17 2024-02-22 Amyris, Inc. Modified beta-1,3-n-acetylglucosaminyltransferase polypeptides
DK180952B1 (en) 2020-12-22 2022-08-10 Glycom As A dfl-producing strain
CA3204530A1 (en) 2021-01-12 2022-07-21 Gregory Mckenzie Synbiotic treatment regimens
WO2022155554A1 (en) * 2021-01-17 2022-07-21 Genomatica, Inc. Methods and compositions for making amide compounds
KR20230134558A (ko) * 2021-01-20 2023-09-21 인바이오스 엔.브이. 숙주 세포에서 코어 구조로서 ln3을 포함하는 올리고당의생산
WO2022157280A1 (en) 2021-01-22 2022-07-28 Glycom A/S New major facilitator superfamily (mfs) protein (fred) in production of sialylated hmos
WO2022168991A1 (ja) * 2021-02-08 2022-08-11 協和発酵バイオ株式会社 フコース含有糖質の輸送活性を有する蛋白質及びフコース含有糖質の製造法
CN115197954A (zh) * 2021-04-14 2022-10-18 上海凯赛生物技术股份有限公司 用于发酵生产1,5-戊二胺的重组dna、菌株及其用途
WO2022219188A1 (en) * 2021-04-16 2022-10-20 Inbiose N.V. Cellular production of sialylated di- and/or oligosaccharides
WO2022243311A1 (en) 2021-05-17 2022-11-24 Dsm Ip Assets B.V. Microbial strain expressing an invertase/sucrose hydrolase
DK181310B1 (en) * 2021-05-17 2023-08-08 Dsm Ip Assets Bv Cell factories for lnt-ii production
DK181497B1 (en) 2021-05-17 2024-03-12 Dsm Ip Assets Bv ENHANCING FORMATION OF THE HMOS LNT AND/OR LNnT BY MODIFYING LACTOSE IMPORT IN THE CELL
DK181242B1 (en) 2021-05-17 2023-05-30 Dsm Ip Assets Bv GENETICALLY ENGINEERED CELLS COMPRISING A RECOMBINANT NUCLEIC ACID SEQUNCE ENCODING AN α-1,2-FUCOSYLTRANSFERASE CAPABLE OF PRODUCING LNFP-I, NUCLEIC ACID SEQUENCES ENCODING SAME AND METHODS FOR USE OF SAME
WO2022242860A1 (en) 2021-05-20 2022-11-24 Chr. Hansen A/S Sequential fermentative production of oligosaccharides
CN113684163B (zh) * 2021-08-04 2023-07-25 江南大学 一种提高乳酰-n-四糖产量的基因工程菌及其生产方法
WO2023120615A1 (ja) * 2021-12-21 2023-06-29 協和発酵バイオ株式会社 コア3糖としてラクト-n-トリオースiiを含む糖質の製造方法および該糖質の結晶の製造方法
WO2023168441A1 (en) * 2022-03-04 2023-09-07 The Regents Of The University Of California Production of milk oligosaccharides in plants
CN116042562B (zh) * 2022-03-11 2023-10-20 山东恒鲁生物科技有限公司 重组酵母菌及其应用
WO2023219437A1 (ko) * 2022-05-11 2023-11-16 (주)에이피테크놀로지 코리네박테리움 글루타미쿰을 이용한 락토-n-테트라오스 및 락토-n-네오테트라오스의 생산 방법
DK202200689A1 (en) 2022-07-15 2024-02-27 Dsm Ip Assets Bv New fucosyltransferases for in vivo synthesis of lnfp-iii
WO2024089131A1 (en) * 2022-10-25 2024-05-02 Inbiose N.V. Saccharide importers for lacto-n-triose

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
US7419795B2 (en) 2003-05-22 2008-09-02 Danisco A/S, Genencor Division Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters
US20070202578A1 (en) * 2005-08-26 2007-08-30 Centre National De La Recherche Scientifique (Cnrs) Production of globosides oligosaccharides using metabolically engineered microorganisms
CN101415834B (zh) * 2006-03-09 2014-09-24 国家科学研究中心 生产涎化低聚糖的方法
GB0909284D0 (en) * 2009-05-29 2009-07-15 Micromass Ltd Acquisition system and method for mass spectrometer data
MY182355A (en) 2009-06-08 2021-01-20 Chr Hansen Hmo Gmbh Hmo synthesis
CN103764835B (zh) * 2011-06-07 2016-08-17 海罗公司 通过生物技术方法获取低聚糖
KR20150128705A (ko) 2013-02-11 2015-11-18 에볼바 에스아 재조합 숙주에서 스테비올 글리코시드의 효율적인 생성
US10364449B2 (en) * 2013-09-06 2019-07-30 Glycom A/S Fermentative production of oligosaccharides
EP2905341B1 (en) * 2014-02-07 2020-04-29 Jennewein Biotechnologie GmbH Methods for producing GDP-fucose using nucleotide sugar transporters and recombinant microorganism host cells used therefor
DK2927316T3 (en) * 2014-03-31 2019-03-04 Jennewein Biotechnologie Gmbh Total fermentation of oligosaccharides

Also Published As

Publication number Publication date
AU2016319304A1 (en) 2018-03-08
CN108026556B (zh) 2023-01-20
CN108026556A (zh) 2018-05-11
US20210277436A1 (en) 2021-09-09
US20180305724A1 (en) 2018-10-25
JP2022105119A (ja) 2022-07-12
MX2018003037A (es) 2019-01-10
PH12018550020A1 (en) 2018-08-13
RU2018109987A3 (pt) 2020-01-27
MX2022003994A (es) 2022-04-26
JP7362831B2 (ja) 2023-10-17
KR20180043297A (ko) 2018-04-27
RU2021135111A (ru) 2021-12-30
RU2018109987A (ru) 2019-10-16
US20210277435A1 (en) 2021-09-09
JP2022105118A (ja) 2022-07-12
RU2763170C2 (ru) 2021-12-28
WO2017042382A1 (en) 2017-03-16
JP7069007B2 (ja) 2022-05-17
US11046985B2 (en) 2021-06-29
JP2018526019A (ja) 2018-09-13
EP3141610A1 (en) 2017-03-15
AU2016319304B2 (en) 2021-04-29
EP3347483A1 (en) 2018-07-18

Similar Documents

Publication Publication Date Title
BR112018004725A2 (pt) método para a produção de oligossacarídeos de leite humano em hospedeiros microbianos com importação/exportação modificada e célula hospedeira microbiana
BR112017014031A2 (pt) n-oligossacaril-transferase recombinante, mutante de n-oligossacaril-transferase recombinante, ácido nucleico, célula hospedeira, e, método para produção de um bioconjugado.
PH12020550039A1 (en) Sialyltransferases and their use in producing sialylated oligosaccharides
BR112019022538A8 (pt) Técnicas para pareamento comportamental em um sistema de centro de contato
BR112017023798A2 (pt) domínios fibronectina tipo iii de ligação a antígeno prostático específico de membrana
BR112016007727A8 (pt) célula hospedeira, e, método para produzir uma proteína n-glicosilada.
WO2014186585A3 (en) Methods and compositions for treatment of a genetic condition
BR112017011542A2 (pt) produção de ácido oleico em levedura
BR112015019603A2 (pt) Moléculas de ácido nucleico isoladas, molécula de polipeptídeo isolada, molécula isolada de car, domínio de ligação anti-egfrviii, vetor, célula e uso de uma quantidade eficaz da mesma e métodos para produção de uma célula e para a produção de uma população de células modificadas por rna
BR112017013956A2 (pt) proteínas de fusão de citocinas
BR112013000822A2 (pt) método e método de duas etapas para a produção de uma população de células exterminadoras naturais (nk) ativadas, população de células nk ativadas e método para suprimir a proliferação de células tumorais
BR112014018630A2 (pt) alvejamento de glicanos de sulfato de condroitina
BR112015010283A8 (pt) bactéria gram-negativa modificada para a produção de um polissacarídeo, glicoproteína recombinante, métodos de produzir uma glicoproteína recombinante e de produzir uma vacina de gliconjugado, célula de e. coli modificada, e, vacina
MX2015008446A (es) Composiciones de proteinas de union multivalentes.
MX351565B (es) Colageno 7 y metodos relacionados.
BR112017023788A2 (pt) composições de ácido nucleico?polímero catiônico e processo para a preparação de dita composição
CY1120493T1 (el) Πρωτεϊνη συντηξης που περιλαμβανει ιντερλευκινη 4 και ιντερλευκινη 10
BR112017001550A2 (pt) enxerto de tecido
BR112016004324A2 (pt) anticorpos
BR112016012371A2 (pt) produção microbial de aminas graxas
MX2016005824A (es) Metodo de cultivo celular.
CY1121859T1 (el) Μεθοδος παρασκευης αναστολεων συνθασης γλυκοζυλοκεραμιδης
MX2016008258A (es) Celulas eucariotas novedosas y metodos para la expresion recombinante de un producto de interes.
BR112016023688A2 (pt) célula hospedeira, métodos para produzir um bioconjugado, para tratar ou prevenir uma infecção por pseudomonas em um indivíduo e para induzir uma resposta imune contra pseudomonas em um indivíduo, bioconjugado, composição, uso de um bioconjugado ou uma composição, e, sequência de ácido nucleico isolada
BR112016025898A2 (pt) ?drimenol sintases e método para produzir drimenol?

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25D Requested change of name of applicant approved

Owner name: CHR. HANSEN HMO GMBH (DE)